Commentary: Superbugs are coming. The US needs to spur the development of new antimicrobials
Chicago is one of a handful of American cities where a deadly fungal infection, Candida auris, has been spreading rapidly. It was first detected five years ago. By 2019, researchers were noting the emergence of a strain of the infection that is resistant to antifungal medications. C. auris is a “superbug” — an antimicrobial-resistant (AMR) infection that does not respond to existing ...
by Latania K. Logan, Chicago Tribune
Jan 21, 2022
2 minutes
Chicago is one of a handful of American cities where a deadly fungal infection, Candida auris, has been spreading rapidly.
It was first detected five years ago. By 2019, researchers were noting the emergence of a strain of the infection that is resistant to antifungal medications.
C. auris is a “superbug” — an antimicrobial-resistant (AMR) infection that does not respond to existing medications such as antifungals. It kills 30%
You’re reading a preview, subscribe to read more.
Start your free 30 days